#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17338	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2115	812.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1680	1680	T	923	T,C	864,5	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17338	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2115	812.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	1036	C	998	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32462	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3466	929.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1586	1586	A	1047	A	1019	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32462	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3466	929.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2220	2220	C	998	C,A	944,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32462	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3466	929.6	0	.	n	.	0	C2847T	SNP	2847	2847	C	3096	3096	T	969	T,C	666,262	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32462	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3466	929.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2294	2294	A	969	A	941	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32462	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3466	929.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2846	2846	C	964	C	927	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2190	folP	855	855	99.88	folP.l15.c30.ctg.1	1605	135.8	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1134	1136	AGC	247;245;246	A;G;C,T	236;233;228,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6188	gyrA	2751	2751	99.93	gyrA.l15.c4.ctg.1	3403	180.5	0	.	p	.	0	D95A	NONSYN	283	285	GAC	527	529	GCC	172;172;172	G;C;C	170;169;168	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6188	gyrA	2751	2751	99.93	gyrA.l15.c4.ctg.1	3403	180.5	1	SNP	p	S91F	1	.	.	271	273	TTC	515	517	TTC	171;171;175	T;T;C	170;170;173	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1898	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1249	149.5	0	.	p	.	0	D79N	NONSYN	235	237	GAT	572	574	AAT	224;228;232	A;A;T	213;215;216	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1898	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1249	149.5	1	SNP	p	G45D	0	.	.	133	135	GGC	470	472	GGC	220;219;218	G;G;C	208;209;208	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1130	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1062	105.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5138	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2936	173.9	0	.	p	.	0	S87N	NONSYN	259	261	AGT	545	547	AAT	201;203;206	A;A;T	195;195;198	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5138	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2936	173.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1436	1438	GTC	195;195;193	G;T,C,G;C	187;180,1,1;184	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5138	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2936	173.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1589	1591	GCA	216;214;213	G,A,T;C,T;A,G	212,1,1;198,1;200,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5138	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2936	173.9	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	193;195;198	G;A;C	188;183;192	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5138	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2936	173.9	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	207;209;211	T;C;C	197;200;203	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4844	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2645	182.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	225;224;223	G;G;C	217;217;211	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1179	1181	GCA	274;276;273	G;C,G,T;A	261;251,1,1;263	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1182	1184	ATC	275;274;273	A;T,C;C	265;258,1;262	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1194	1196	GTG	267;271;270	G;T;G	256;256;258	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1194	1196	GTG	267;271;270	G;T;G	256;256;258	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1698	1700	ACC	245;242;244	A;C;C	231;233;238	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1752	1754	GCG	224;221;221	G;C,G;G	211;188,3;205	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1752	1754	GCG	224;221;221	G;C,G;G	211;188,3;205	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1875	1877	GGT	216;214;211	G,C;G;T	210,1;208;202	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1884	1886	GGC	203;195;198	G,A;G;C	192,1;185;188	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4774	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2279	207.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1902	1904	CCG	171;172;172	C,G;C,G;G	126,6;137,1;142	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6962	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3029	228.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1635	1637	CCG	265;265;262	C,A,G;C,G;G,C	250,1,1;253,1;246,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2776	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1684	162.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	198	C	192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	T26A	NONSYN	76	78	ACC	454	456	GCC	304;308;310	G;C;C	287;292;294	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	490	492	GAA	300;296;292	G;A;A	289;285;281	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	901	903	TCA	278;279;277	T;C;A	268;268;268	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	937	939	CAA	290;293;293	CAAAA,CAAA;A,C;A	269,1;274,2;274	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	G189S	NONSYN	565	567	GGC	943	945	AGC	299;300;303	A;G;C	281;281;285	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	F215T	NONSYN	643	645	TTT	1021	1023	ACT	302;301;302	A;C;T	293;294;296	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1030	1032	GTG	290;290;286	G;T;G	283;280;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1102	1104	GTT	259;262;257	G;T;T	244;248;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3482	porB1b	1047	1047	97.9	porB1b.l15.c4.ctg.1	1638	211.3	0	.	p	.	0	V293A	NONSYN	877	879	GTT	1255	1257	GCT	268;269;270	G;C;T	261;261;260	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	12860	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4832	264.3	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1988	1990	AAT	319;316;317	A,C;A;T	310,1;304;304	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1546	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	960	159.1	1	SNP	p	V57M	1	.	.	169	171	ATG	417	419	ATG	325;326;329	A;T;G	314;311;312	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	879	881	ACG	505;497;496	A;C,A;G	484;481,2;481	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	900	902	GAC	447;448;447	G,A;A;C	443,1;439;442	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	918	920	ATG	457;458;451	A;T;G	457;456;450	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	930	932	TCA	451;450;448	T;C;A	448;444;447	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	975	977	CAG	442;444;446	C;A;G	438;439;441	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	V216L	NONSYN	646	648	GTT	996	998	CTT	430;424;422	C;T;T	425;423;421	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1017	1019	AGT	398;404;406	A;G;T	388;398;386	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1086	1088	CCG	539;537;539	C;C;G	517;516;517	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1188	1190	TCG	612;610;615	T;C;G	588;582;592	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1359	1361	AAA	387;382;382	A;A;A	371;367;367	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1362	1364	AAG	374;368;367	A;A,G;G,C	363;356,1;357,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1377	1379	CAC	308;309;312	C;A,C;C	306;290,2;310	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1416	1418	GAA	313;308;309	G;A;A	309;307;308	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1494	1496	ACG	219;218;214	A;C;G	216;215;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1545	1547	ATT	293;293;294	A;T;T	284;286;289	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1548	1550	AGT	292;289;289	A;G;T	286;284;280	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1587	1589	CTA	344;345;350	C,A;T,A;A	334,1;336,1;342	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1629	1631	AAT	244;241;242	A;A;T	240;240;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1698	1700	TCA	334;334;330	T;C;A	329;329;316	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1722	1724	ATG	348;348;349	A;T;G	343;343;347	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2016	2018	ACC	722;721;730	A,T,C;C;C	680,1,1;691;696	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12758	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2514	503.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2112	2114	GAA	685;685;688	G;A;A	672;674;676	.	Tetracycline resistance
